ANI Pharmaceuticals
ANIP
#5255
Rank
A$2.35 B
Marketcap
A$103.57
Share price
-0.84%
Change (1 day)
-16.10%
Change (1 year)

EPS for ANI Pharmaceuticals (ANIP)

EPS in 2026 (TTM): A$7.54

According to ANI Pharmaceuticals's latest financial reports the company's current EPS (TTM) is A$7.83. In 2025 the company made an earnings per share (EPS) of A$5.29 an increase over its 2024 EPS that were of A-$1.69.

EPS history for ANI Pharmaceuticals from 2013 to 2026

Annual EPS

Year EPS Change
2026 (TTM)A$7.5442.56%
2025A$5.29-412.5%
2024A-$1.69
2022A-$4.59-6.46%
2021A-$4.9172.87%
2020A-$2.84-476%
2019A$0.76-62.12%
2018A$1.99
2015A$2.02-47.66%
2014A$3.87-142.11%
2013A-$9.19

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Novartis
NVS
A$7.93 1.35%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
A$1.07-86.29%๐Ÿ‡บ๐Ÿ‡ธ USA
Cardinal Health
CAH
A$11.72 49.81%๐Ÿ‡บ๐Ÿ‡ธ USA
Jazz Pharmaceuticals
JAZZ
A$5.48-29.92%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Evoke Pharma
EVOK
A-$3.81-148.65%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
A-$6.57-183.98%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
A$0.68-91.31%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Royalty Pharma
RPRX
A$2.31-70.48%๐Ÿ‡ฌ๐Ÿ‡ง UK
Lannett Company
LCI
A-$38.19-588.03%๐Ÿ‡บ๐Ÿ‡ธ USA